Similar age-specific PSA, complexed PSA, and percent cPSA levels among African-American and white men of Southern Louisiana

Urology

Volumn 61, Issue 2, 2003, Pages 375-379

  Martin, Benjamin ^b   Cheli, Carol ^b   Pollard, Steven ^b   Sullivan, Jerry ^b   Goodman, Jack ^b   Kokatnur, Mohan ^b   Ward, Maria ^b   Martin, Laraine ^b   Mercante, Don ^b   Rayford, Walter ^a  

^a LOUISIANA STATE UNIV HLTH SCI C   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CAUCASIAN; EVALUATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NEGRO; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN VARIANT; RACE DIFFERENCE; RECTUM; UNITED STATES;

EID: 0037319284     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02246-X     Document Type: Article

References (29)

1. Miller B.A., Ries L.A.G., Hankey B.F., et al. Cancer Statistics Review: 1973-1989. 1992;National Cancer Institute, Bethesda.
2. Gargiullo P., Wingo P.A., Coates R.J., et al. Recent trends in mortality rates for four major cancers, by sex and race - United States, 1990-1998. MMWR Morb Mortal Wkly Rep. 51:2002;49-53.
3. Abdalla I., Ray P., Vijayakumar S. Race and serum prostate specific antigen levels current status and future directions . Semin Urol Oncol. 16:1998;207-213.
4. Brawley O.W. Prostate cancer and black men. Semin Urol Oncol. 16:1998;184-186.
5. Smith D.S., Bullock A.D., Catalona W.J. Racial differences in a prostate cancer screening study. J Urol. 156:1996;1366-1369.
6. Fowler J.E., Sanders J., Bigler S.A., et al. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng/mL. J Urol. 163:2000;1467-1470.
7. Pettaway C.A., Troncoso P., Ramirez E.I., et al. Prostate specific antigen and pathological features of prostate cancer in black and white patients a comparative study based on radical prostatectomy specimens . J Urol. 160:1998;437-442.
8. Moul J.W., Sesterhern I.A., Connelly R.R., et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 274:1995;1277-1281.
9. Vijayakumar S., Karrison T., Weichselbaum R.R., et al. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biomarkers Prev. 1:1992;541-545.
10. DeAntoni E.P., Crawford E.D., Oesterling J.E., et al. Age- and race-specific reference ranges for prostate specific antigen from a large community-based study. Urology. 48:1996;234-239.
11. Morgan T.O., Jacobsen S.J., McCarthy W.F., et al. Age-specific reference ranges for serum prostate-specific antigen in black men. N Engl J Med. 335:1996;304-310.
12. Powell I.J., Heilbrun L., Littrup P., et al. Outcome of African American men screened for prostate cancer the Detroit Education and Early Detection study . J Urol. 158:1997;146-149.
13. Montie J.E., Pienta K.J. A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men. Urology. 53:1999;1073-1076.
14. Sakr W.A., Grignon D.J., Haas G.P. Pathology of pre-malignant lesions and carcinoma of the prostate in African American men. Semin Urol Oncol. 16:1998;214-220.
15. Allard W.J., Zhou Z., Yeung K.K. Novel immunoassay for the measurement of complexed prostate specific antigen in serum. Clin Chem. 44:1998;1216-1223.
16. Brawer M.K., Meyer G.E., Letran J.L. Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology. 52:1998;372-378.
17. Cheli CD, Bartsch G, Horninger W, et al: Final results of a multicenter prospective evaluation of complexed PSA for early detection of prostate cancer (abstract). Presented at the 2002 American Urological Association Annual Meeting.
18. Eastham J.A., Sartor O., Richey W., et al. Racial variation in prostate specific antigen in a large cohort of men without prostate cancer. J La State Med Soc. 153:2001;184-189.
19. Weinrich M.C., Jacobsen S.J., Weinrich S.P., et al. Reference ranges for serum prostate-specific antigen in black and white men without cancer. Urology. 52:1998;967-973.
20. Cooney K.A., Strawderman M.S., Wojno K.J., et al. Age-specific distribution of serum prostate specific antigen in a community-based study of African-American men. Urology. 57:2001;91-96.
21. Catalona W.J., Partin A.W., Slawin K.M., et al. Use of percentage free prostatic specific antigen to enhance differentiation of prostate cancer from benign prostate disease a prospective multicenter trial . JAMA. 279:1998;1542-1547.
22. Catalona W.J., Partin A.W., Slawin K.M., et al. Percentage of free PSA in black men versus white men for detection and staging of prostate cancer a prospective multicenter clinical trial . Urology. 55:2000;372-376.
23. Okihara K., Cheli C.D., Partin A.W., et al. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol. 167:2002;2017-2024.
24. Stamey T.A., Yang N., Hay A.R., et al. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:1987;909-916.
25. Catalona W.J., Smith D.S., Ornstein D.K. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination enhancement of specificity with free PSA measurements . JAMA. 277:1997;1452-1455.
26. Smith D.S., Carvalhal G.F., Mager D.E., et al. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol. 160:1998;1734-1738.
27. Paquette E.L., Connelly R.R., Sesterhann I.A., et al. Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era. Cancer. 92:2001;2673-2679.
28. Jani A.B., Vaida F., Hanks G., et al. Changing face and different countenances of prostate cancer racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era . Int J Cancer. 96:2001;363-371.
29. Etzioni R., Berry K.M., Legler J.M., et al. Prostate specific antigen testing in black and white men an analysis of Medicare claims from 1991-1998 . Urology. 59:2002;251-255.